康诺亚生物医药科技有限公司（下称“康诺亚-B”，股票代码：02162）于2026年4月1日披露2026年3月股份变动月报表。公告显示，截至2026年3月31日，公司注册股本维持在500,000,000股（每股面值0.0001美元），相当于总额50,000美元，较上月无任何增减变动。
公司已发行股份数为298,735,566股，与上月底保持一致。报告期间内，公司未进行任何新增发行、购回或注销股份，也无库存股变动。此外，公司在期权与激励计划方面并无变化。
截至本月末，公司股本总数保持稳定。公司声明已遵守香港联交所《上市规则》及相关法律规定。该公告由执行董事Bo CHEN博士签署。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.